Exploring Racial Disparities in Sleep Health and Neurocognitive Function

University of Alabama, Tuscaloosa

Status: Completed

Conditions: HIV Dementia

Treatments: Other: electroencephalography (EEG) and event related potentials (ERP)

Study type: Interventional

Funder types: Other

Identifiers

NCT04015830

UATuscaloosa

Details and patient eligibility

About

Despite longer life expectancies due to combination antiretroviral therapy (cART), the prevalence of HIV-associated neurocognitive disorders (HAND) persists thus affecting 52% of the HIV population. Poor sleep quality is commonly reported in older adults and has been related to neurocognitive impairments. This is concerning given studies have shown that up to 75% of adults with HIV experience poor sleep, and by 2020, 70% of adults with HIV will be age 50 and older. It is important to examine sleep quality as it relates to neurocognitive function and HAND in older adults with HIV given its negative impact on cART adherence. Compared to Whites with HIV, African Americans (AA) are disproportionately affected by HIV and are more likely to experience poor sleep quality. This primary goal of this 1-year cross-sectional study is to examine racial differences in sleep quality and neurocognitive function among 60 African Americans and Whites with HIV (age 50+).

Full description

This study is designed with two aims: Aim 1a: To explore differences in sleep health between older HIV+ AA and Whites. 1b: To explore differences in domain-specific neurocognitive impairments between older HIV+ AA and Whites. Aim 2a: To explore the relationship between sleep health and neurocognitive function. 2b: To explore the relationship between sleep health and cART adherence. 2c: To explore mediation effects of cART adherence between sleep health and neurocognitive function. This is the first study to explore racial disparities in sleep health and neurocognitive function, using EEG/ERP metrics, among older HIV+ adults. There are two phases in this study: Phase I which consists of neurocognitive testing and sleep assessments with actigraphy, and Phase II which consist of a 20-30 min EEG. Measurements of electrical brain activity will be captured while participants engage in an Attention Network Test which measures executive function, attention, and speed of processing.

Enrollment: 30 patients

Sex: All

Ages: 50+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• HIV+
• Identify as AA or White
• 50 years old or older
• Speak English

Exclusion criteria

• Alzheimer's disease or dementia
• Severe neurocognitive impairment (>7 errors on the Short Portable Mental Status Questionnaire)
• Deaf or blind
• Currently undergoing radiation/chemotherapy
• Brain trauma with loss of consciousness greater than 30 minutes
• A learning disability
• Significant neuromedical comorbidities (e.g., schizophrenia)
• Currently taking Efavirenz
• Moderate to severe sleep apnea
• Restless leg syndrome
• Narcolepsy
• Left handedness

Trial design

Primary purpose: Basic Science

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

30 participants in 1 patient group

Older Adults with HIV (N = 60)

Experimental group

Description:

African Americans and Whites age 50 and older

Treatment:

Other: electroencephalography (EEG) and event related potentials (ERP)